Importantly, these benefits were achieved with just one - third the rate of serious adverse events reported in the standard chemotherapy group. (sciencedaily.com)
This scale reflects the number of stressful life events reported, ranging from 0 to 8. (journals.plos.org)
The therapy had a favorable safety profile with the most common adverse event reported as irritation at injection site, which was reported in the placebo group as well. (sciencedaily.com)